Security key
00848H108
SERINA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (AGE)
CUSIP: 00848H108
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 4,967,397
- Total 13F value
- $1,912,387
- Share change
- +142,851
- SEC-reported price per share
- $0.38
- Number of holders
- 35
- Value change
- +$54,930
- Number of buys
- 11
- Number of sells
- 8
- Shares outstanding
- 16,120,077
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
35
Top holders
10
AGE full security history
Ownership snapshot
Full 13F holder table
Serina Therapeutics, Inc. SEC filings
Serina Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AGE - SERINA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Juvenescence US Corp.
Disclosed value leader
Juvenescence US Corp.
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5
13F
Highest disclosed value: $9,704,025
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Juvenescence US Corp. has the largest disclosed position value at $9.7M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Juvenescence US Corp.'s linked filing trail.
Disclosed position value
Top 5
Juvenescence US Corp.
$9.7M
BROADWOOD CAPITAL INC
$2.04M
VANGUARD GROUP INC
$474.9K
Prescott General Partners LLC
$125.9K
Sigma Planning Corp
$123.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Juvenescence US Corp. |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
$9,704,025
16,447,500 shares
|
— | 14 Mar 2023 |
| BROADWOOD CAPITAL INC |
13F
Company
|
—
denominator unverified
|
$2,038,066
2,997,156 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$474,921
698,414 shares
|
— | 30 Sep 2023 |
| Prescott General Partners LLC |
13F
Company
|
—
denominator unverified
|
$125,926
185,185 shares
|
— | 30 Sep 2023 |
| Sigma Planning Corp |
13F
Company
|
—
denominator unverified
|
$123,342
181,385 shares
|
— | 30 Sep 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$98,444
144,770 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
4,967,397
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
28
Q4 2023 holders
35
Holder diff
7
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|